Kukje Pharma Co Ltd (002720) — Capital Reinvestment Ratio
Kukje Pharma Co Ltd (002720) has a Capital Reinvestment Ratio of 0.10x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩4.99 Billion) in capital expenditures (₩474.52 Million). See 002720 net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Kukje Pharma Co Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Kukje Pharma Co Ltd's Capital Reinvestment Ratio across 11 annual periods. Check 002720 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Kukje Pharma Co Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Kukje Pharma Co Ltd from 2011 to 2024. For live market cap and broader valuation context, see market value of Kukje Pharma Co Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.76x | ₩3.94 Billion | ₩2.99 Billion | ▲ +159.8% |
| 2023 | 0.29x | ₩3.58 Billion | ₩1.05 Billion | ▲ +51.1% |
| 2022 | 0.19x | ₩6.50 Billion | ₩1.26 Billion | ▼ -1.8% |
| 2021 | 0.20x | ₩9.60 Billion | ₩1.89 Billion | ▼ -91.3% |
| 2020 | 2.27x | ₩5.10 Billion | ₩11.60 Billion | ▲ +39.2% |
| 2019 | 1.63x | ₩3.60 Billion | ₩5.89 Billion | ▲ +615.1% |
| 2018 | 0.23x | ₩13.25 Billion | ₩3.03 Billion | ▼ -93.1% |
| 2017 | 3.32x | ₩786.10 Million | ₩2.61 Billion | ▲ +1889.6% |
| 2016 | 0.17x | ₩16.10 Billion | ₩2.69 Billion | ▼ -83.4% |
| 2012 | 1.00x | ₩1.58 Billion | ₩1.59 Billion | ▲ +1641.9% |
| 2011 | 0.06x | ₩17.39 Billion | ₩1.00 Billion | — |